Analysis of Start-Up, Retention, and Adherence in ALS Clinical Trials

Neurology - United States
doi 10.1212/wnl.0b013e3182a823e0
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Use of Biomarkers in ALS Drug Development and Clinical Trials

Brain Research
NeuroscienceNeurologyDevelopmental BiologyMolecular Biology
2015English

The Double Mediating Effect of Start-Up Motive and Start-Up Spirit Between Start-Up Opportunity Awareness and Expected Outcome Af a Start-Up

International Journal of Recent Technology and Engineering
EngineeringManagement of TechnologyInnovation
2019English

Data Retention After a Patient Withdraws Consent in Clinical Trials

Open Access Journal of Clinical Trials
ToxicologyPharmaceuticsPharmacology
2011English

Adaptive Sample Size Modification in Clinical Trials: Start Small Then Ask for More?

Statistics in Medicine
EpidemiologyStatisticsProbability
2015English

Start-Up Dynamics

OECD Science, Technology and Industry Scoreboard
2017English

Start Up and Saturation in Monotrons

2007English

An Analysis of Eco System of Indian Start-Ups and Post Start-Up Scenario of Selected Companies

PRAGATI : Journal of Indian Economy
2017English

Moving Forward in Clinical Trials for ALS: Motor Neurons Lead the Way Please

Drug Discovery Today
Drug DiscoveryPharmacology
2014English

Analysis of Clinical Drug Trials in Children Compared to Clinical Drug Trials in Adults, in Argentina

Archivos Argentinos de Pediatria
Child HealthPediatricsPerinatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy